Canopy Growth Corporation (CGC)

NasdaqGS • Currently down 0.01 (-1.00%) in today's trading session

2 members of Congress have disclosed 6 trades in Canopy Growth Corporation (CGC) via STOCK Act filings. The most recent disclosure was a purchase by John A. Yarmuth on 12 February 2021. The most active traders have been John A. Yarmuth (5) and Brenda L. Lawrence (1). Aggregate disclosed activity totals roughly $40K in purchases and $8K in sales (midpoint estimates from bracketed disclosure amounts).

Canopy Growth Corporation is currently trading at $0.67, positioned at 1% of its 52-week range ($0.65 – $2.38).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$0.67
24h Change
-0.01 (-1.00%)
52 Week Range
$0.65–$2.38
View on NASDAQ

Canopy Growth Corporation Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for CGC

Select to highlight on chart
5 transactions
Compliance: 83%
John A. Yarmuth12 Feb 202119 Feb 2021PurchaseStock$1,001 - $15,000N/A
John A. Yarmuth12 Feb 202128 Jul 2022PurchaseStock$1,001 - $15,000N/A
John A. Yarmuth5 Nov 202015 Nov 2020PurchaseStock$1,001 - $15,000N/A
John A. Yarmuth10 Mar 202011 Aug 2021PurchaseStock$1,001 - $15,000N/A
John A. Yarmuth10 Mar 20202 May 2020SaleStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$281.45M

Volume

2.13M

Beta

2.41

P/E Ratio

-1.49

Fundamentals

EPS

$-0.45

Div. Yield

-

Open

$0.67

Day Range

$0.65 – $0.69

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ · USD
Country
CA
CEO
Luc Mongeau
IPO Date
2014-04-07

Canopy Growth Corporation (CGC), alongside its affiliated businesses, specializes in the cultivation, marketing, and retail of both cannabis and hemp-derived products. These offerings are designed for both recreational consumption and therapeutic use...

Earnings

Next Report

Q3 2026

6 Nov

EPS Est.

$-0.03

Rev. Est.

$57.7M

Days Until

15

Recent Quarters

Q2 20267 Aug
EPS$-0.02
Beat 50.0%
Q1 202615 Jun
EPS$-0.29
Miss 379.3%
Q4 202531 Mar
EPS$-0.13
Miss 218.6%
Q4 20256 Feb
EPS$-0.18
Miss 218.6%
Q3 202515 Dec
EPS$-0.01
Beat 93.6%
Q3 20257 Nov
EPS$-0.01
Beat 93.6%
Q2 20258 Aug
EPS$-0.22
Beat 4.8%
Q1 202530 May
EPS$-1.43
Miss 209.6%
Q4 20247 Feb
EPS$-1.11
Miss 113.5%
Q3 20248 Nov
EPS$-1.48
Miss 236.4%
Q2 20249 Aug
EPS$-1.60
Miss 247.8%
Q1 202430 May
EPS$-1.03
Miss 128.9%
Q4 20239 Feb
EPS$-2.62
Miss 434.7%
Q3 20239 Nov
EPS$-1.80
Miss 50.0%
Q2 20239 Aug
EPS$-0.07
Beat 53.3%
Q1 202322 Jun
EPS$-2.30
Miss 1050.0%
Q4 20229 Feb
EPS$-0.54
Miss 134.8%
Q3 20229 Nov
EPS$-0.47
Beat 82.6%
Q2 20225 Aug
EPS$-7.00
Miss 250.0%
Q1 202227 May
EPS$-1.47
Beat 38.8%
Q4 20219 Feb
EPS$-2.20
Beat 4.3%
Q3 20215 Nov
EPS$-0.03
Beat 86.4%
Q2 20216 Aug
EPS$0.84
Beat 411.1%
Q1 20211 Jun
EPS$-1.85
Miss 611.5%
Q4 20209 Feb
EPS$-2.43
Miss 594.3%
Q3 20209 Nov
EPS$-0.17
Beat 52.8%
Q2 202010 Aug
EPS$-0.25
Beat 43.2%
Q1 202029 May
EPS$-1.55
Miss 162.7%
Q4 201914 Feb
EPS$-0.35
Beat 28.6%
Q3 201914 Nov
EPS$-0.96
Miss 140.0%
Q2 201914 Aug
EPS$-0.30
Beat 18.9%
Q1 201920 Jun
EPS$-6.70
Miss 294.1%
Q4 201814 Feb
EPS$-0.38
Miss 137.5%
Q3 201814 Nov
EPS$-1.50
Miss 1150.0%
Q2 201814 Aug
EPS$-0.10
Beat 23.1%
Q1 201827 Jun
EPS$-1.00
Miss 614.3%
Q4 201714 Feb
EPS$-0.02
Beat 60.0%
Q3 201714 Nov
EPS$-0.01
Beat 75.1%
Q2 201714 Aug
EPS$-0.03
Beat 31.2%
Q4 201614 Feb
EPS$0.02
Beat 166.7%
Q3 201614 Nov
EPS$0.05
Beat 350.0%
Q2 201629 Aug
EPS$-0.04
Miss 33.3%
Q4 201525 Feb
EPS$-0.03
Miss 50.0%
Q3 201526 Nov
EPS$0.07
Beat 240.0%
Q2 201531 Aug
EPS$0.02
Q4 201426 Feb
EPS$-0.07
Miss 75.0%
Q3 201425 Nov
EPS$-0.07

2 politicians traded within 30 days

No dividend data available for this stock.

Stock Splits

Split History

20 Dec 2023Reverse Split
Ratio1:10

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

AMZN

Amazon.com, Inc.

44
$250.38-11.99 (-4.57%)
Consumer Cyclical
2 politicians both hold this
2 politicians
View Stock

AAPL

Apple Inc.

44
$348.22+4.23 (+1.23%)
Technology
2 politicians both hold this
2 politicians
View Stock

NVDA

NVIDIA Corporation

35
$212.21-9.76 (-4.40%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

Frequently Asked Questions about CGC

Which members of Congress have traded CGC?
2 members of Congress have disclosed 6 trades in Canopy Growth Corporation (CGC) under the STOCK Act. The most active traders are John A. Yarmuth and Brenda L. Lawrence.
When was CGC most recently disclosed by Congress?
The most recent CGC disclosure was a purchase by John A. Yarmuth on 12 February 2021.
What is the total disclosed congressional trading volume for CGC?
Members of Congress have disclosed approximately $40K in CGC purchases and $8K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in CGC?
This CGC page updates as soon as new STOCK Act disclosures are filed for Canopy Growth Corporation. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.